調査レポート | • レポートコード：GIR-2104Z06447 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、緑内障治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。緑内障治療薬の種類別市場規模（プロスタグランジン類似体、ベータ遮断薬、アルファアゴニスト、炭酸脱水酵素阻害薬、併用薬）、用途別市場規模（開放隅角緑内障、閉鎖隅角緑内障）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・緑内障治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Novartis、bausch Lomb、Laboratoire Riva、Jamp Pharma、Fresenius、Teva Pharmaceutical?、SANDOZ、Greenstone、Mylan、GE Medical、Mint Pharmaceuticals、Laboratoires Thea、Taj Pharmaceuticals、Actavis、APOTEX、Sun Pharma ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：プロスタグランジン類似体、ベータ遮断薬、アルファアゴニスト、炭酸脱水酵素阻害薬、併用薬 ・用途別分析2016年-2026年：開放隅角緑内障、閉鎖隅角緑内障 ・緑内障治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・緑内障治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・緑内障治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・緑内障治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・緑内障治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Glaucoma Medications market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Glaucoma Medications size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Glaucoma Medications market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Glaucoma Medications market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Prostaglandin Analogs
Beta Blockers
Alpha Agonists
Carbonic Anhydrase Inhibitors
Combined Medications
Market segment by Application can be divided into
Open-angle Glaucoma
Closed-angle Glaucoma
The key market players for global Glaucoma Medications market are listed below:
Pfizer
Novartis
bausch Lomb
Laboratoire Riva
Jamp Pharma
Fresenius
Teva Pharmaceutical?
SANDOZ
Greenstone
Mylan
GE Medical
Mint Pharmaceuticals
Laboratoires Thea
Taj Pharmaceuticals
Actavis
APOTEX
Sun Pharma
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Glaucoma Medications Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Glaucoma Medications Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Prostaglandin Analogs
1.2.3 Beta Blockers
1.2.4 Alpha Agonists
1.2.5 Carbonic Anhydrase Inhibitors
1.2.6 Combined Medications
1.3 Market Analysis by Application
1.3.1 Overview: Global Glaucoma Medications Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Open-angle Glaucoma
1.3.3 Closed-angle Glaucoma
1.4 Global Glaucoma Medications Market Size & Forecast
1.4.1 Global Glaucoma Medications Sales in Value (2016-2026))
1.4.2 Global Glaucoma Medications Sales in Volume (2016-2026)
1.4.3 Global Glaucoma Medications Price by Type (2016-2026) & (USD/Kg)
1.5 Global Glaucoma Medications Production Capacity Analysis
1.5.1 Global Glaucoma Medications Total Production Capacity (2016-2026)
1.5.2 Global Glaucoma Medications Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Glaucoma Medications Market Drivers
1.6.2 Glaucoma Medications Market Restraints
1.6.3 Glaucoma Medications Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Glaucoma Medications Product and Services
2.1.4 Pfizer Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Glaucoma Medications Product and Services
2.2.4 Novartis Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 bausch Lomb
2.3.1 bausch Lomb Details
2.3.2 bausch Lomb Major Business
2.3.3 bausch Lomb Glaucoma Medications Product and Services
2.3.4 bausch Lomb Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Laboratoire Riva
2.4.1 Laboratoire Riva Details
2.4.2 Laboratoire Riva Major Business
2.4.3 Laboratoire Riva Glaucoma Medications Product and Services
2.4.4 Laboratoire Riva Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Jamp Pharma
2.5.1 Jamp Pharma Details
2.5.2 Jamp Pharma Major Business
2.5.3 Jamp Pharma Glaucoma Medications Product and Services
2.5.4 Jamp Pharma Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Fresenius
2.6.1 Fresenius Details
2.6.2 Fresenius Major Business
2.6.3 Fresenius Glaucoma Medications Product and Services
2.6.4 Fresenius Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Teva Pharmaceutical?
2.7.1 Teva Pharmaceutical? Details
2.7.2 Teva Pharmaceutical? Major Business
2.7.3 Teva Pharmaceutical? Glaucoma Medications Product and Services
2.7.4 Teva Pharmaceutical? Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 SANDOZ
2.8.1 SANDOZ Details
2.8.2 SANDOZ Major Business
2.8.3 SANDOZ Glaucoma Medications Product and Services
2.8.4 SANDOZ Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Greenstone
2.9.1 Greenstone Details
2.9.2 Greenstone Major Business
2.9.3 Greenstone Glaucoma Medications Product and Services
2.9.4 Greenstone Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Mylan
2.10.1 Mylan Details
2.10.2 Mylan Major Business
2.10.3 Mylan Glaucoma Medications Product and Services
2.10.4 Mylan Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 GE Medical
2.11.1 GE Medical Details
2.11.2 GE Medical Major Business
2.11.3 GE Medical Glaucoma Medications Product and Services
2.11.4 GE Medical Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Mint Pharmaceuticals
2.12.1 Mint Pharmaceuticals Details
2.12.2 Mint Pharmaceuticals Major Business
2.12.3 Mint Pharmaceuticals Glaucoma Medications Product and Services
2.12.4 Mint Pharmaceuticals Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Laboratoires Thea
2.13.1 Laboratoires Thea Details
2.13.2 Laboratoires Thea Major Business
2.13.3 Laboratoires Thea Glaucoma Medications Product and Services
2.13.4 Laboratoires Thea Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Taj Pharmaceuticals
2.14.1 Taj Pharmaceuticals Details
2.14.2 Taj Pharmaceuticals Major Business
2.14.3 Taj Pharmaceuticals Glaucoma Medications Product and Services
2.14.4 Taj Pharmaceuticals Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Actavis
2.15.1 Actavis Details
2.15.2 Actavis Major Business
2.15.3 Actavis Glaucoma Medications Product and Services
2.15.4 Actavis Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 APOTEX
2.16.1 APOTEX Details
2.16.2 APOTEX Major Business
2.16.3 APOTEX Glaucoma Medications Product and Services
2.16.4 APOTEX Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.17 Sun Pharma
2.17.1 Sun Pharma Details
2.17.2 Sun Pharma Major Business
2.17.3 Sun Pharma Glaucoma Medications Product and Services
2.17.4 Sun Pharma Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Glaucoma Medications Sales by Manufacturer
3.1 Global Glaucoma Medications Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Glaucoma Medications Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Glaucoma Medications
3.4 Market Concentration Rate
3.4.1 Top 3 Glaucoma Medications Manufacturer Market Share
3.4.2 Top 6 Glaucoma Medications Manufacturer Market Share
3.5 Global Glaucoma Medications Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Glaucoma Medications Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Glaucoma Medications Market Size by Region
4.1.1 Global Glaucoma Medications Sales in Volume by Region (2016-2026)
4.1.2 Global Glaucoma Medications Revenue by Region (2016-2026)
4.2 North America Glaucoma Medications Revenue (2016-2026)
4.3 Europe Glaucoma Medications Revenue (2016-2026)
4.4 Asia-Pacific Glaucoma Medications Revenue (2016-2026)
4.5 South America Glaucoma Medications Revenue (2016-2026)
4.6 Middle East and Africa Glaucoma Medications Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Glaucoma Medications Sales in Volume by Type (2016-2026)
5.2 Global Glaucoma Medications Revenue by Type (2016-2026)
5.3 Global Glaucoma Medications Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Glaucoma Medications Sales in Volume by Application (2016-2026)
6.2 Global Glaucoma Medications Revenue by Application (2016-2026)
6.3 Global Glaucoma Medications Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Glaucoma Medications Sales by Type (2016-2026)
7.2 North America Glaucoma Medications Sales by Application (2016-2026)
7.3 North America Glaucoma Medications Market Size by Country
7.3.1 North America Glaucoma Medications Sales in Volume by Country (2016-2026)
7.3.2 North America Glaucoma Medications Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Glaucoma Medications Sales by Type (2016-2026)
8.2 Europe Glaucoma Medications Sales by Application (2016-2026)
8.3 Europe Glaucoma Medications Market Size by Country
8.3.1 Europe Glaucoma Medications Sales in Volume by Country (2016-2026)
8.3.2 Europe Glaucoma Medications Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Glaucoma Medications Sales by Type (2016-2026)
9.2 Asia-Pacific Glaucoma Medications Sales by Application (2016-2026)
9.3 Asia-Pacific Glaucoma Medications Market Size by Region
9.3.1 Asia-Pacific Glaucoma Medications Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Glaucoma Medications Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Glaucoma Medications Sales by Type (2016-2026)
10.2 South America Glaucoma Medications Sales by Application (2016-2026)
10.3 South America Glaucoma Medications Market Size by Country
10.3.1 South America Glaucoma Medications Sales in Volume by Country (2016-2026)
10.3.2 South America Glaucoma Medications Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Glaucoma Medications Sales by Type (2016-2026)
11.2 Middle East & Africa Glaucoma Medications Sales by Application (2016-2026)
11.3 Middle East & Africa Glaucoma Medications Market Size by Country
11.3.1 Middle East & Africa Glaucoma Medications Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Glaucoma Medications Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Glaucoma Medications Typical Distributors
12.3 Glaucoma Medications Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Glaucoma Medications Revenue by Type, (USD Million), 2021-2026
Table 2. Global Glaucoma Medications Revenue by Application, (USD Million), 2021-2026
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Glaucoma Medications Product and Services
Table 6. Pfizer Glaucoma Medications Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Major Business
Table 9. Novartis Glaucoma Medications Product and Services
Table 10. Novartis Glaucoma Medications Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. bausch Lomb Basic Information, Manufacturing Base and Competitors
Table 12. bausch Lomb Major Business
Table 13. bausch Lomb Glaucoma Medications Product and Services
Table 14. bausch Lomb Glaucoma Medications Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Laboratoire Riva Basic Information, Manufacturing Base and Competitors
Table 16. Laboratoire Riva Major Business
Table 17. Laboratoire Riva Glaucoma Medications Product and Services
Table 18. Laboratoire Riva Glaucoma Medications Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Jamp Pharma Basic Information, Manufacturing Base and Competitors
Table 20. Jamp Pharma Major Business
Table 21. Jamp Pharma Glaucoma Medications Product and Services
Table 22. Jamp Pharma Glaucoma Medications Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Fresenius Basic Information, Manufacturing Base and Competitors
Table 24. Fresenius Major Business
Table 25. Fresenius Glaucoma Medications Product and Services
Table 26. Fresenius Glaucoma Medications Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Teva Pharmaceutical? Basic Information, Manufacturing Base and Competitors
Table 28. Teva Pharmaceutical? Major Business
Table 29. Teva Pharmaceutical? Glaucoma Medications Product and Services
Table 30. Teva Pharmaceutical? Glaucoma Medications Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. SANDOZ Basic Information, Manufacturing Base and Competitors
Table 32. SANDOZ Major Business
Table 33. SANDOZ Glaucoma Medications Product and Services
Table 34. SANDOZ Glaucoma Medications Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Greenstone Basic Information, Manufacturing Base and Competitors
Table 36. Greenstone Major Business
Table 37. Greenstone Glaucoma Medications Product and Services
Table 38. Greenstone Glaucoma Medications Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Mylan Basic Information, Manufacturing Base and Competitors
Table 40. Mylan Major Business
Table 41. Mylan Glaucoma Medications Product and Services
Table 42. Mylan Glaucoma Medications Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. GE Medical Basic Information, Manufacturing Base and Competitors
Table 44. GE Medical Major Business
Table 45. GE Medical Glaucoma Medications Product and Services
Table 46. GE Medical Glaucoma Medications Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Mint Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 48. Mint Pharmaceuticals Major Business
Table 49. Mint Pharmaceuticals Glaucoma Medications Product and Services
Table 50. Mint Pharmaceuticals Glaucoma Medications Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Laboratoires Thea Basic Information, Manufacturing Base and Competitors
Table 52. Laboratoires Thea Major Business
Table 53. Laboratoires Thea Glaucoma Medications Product and Services
Table 54. Laboratoires Thea Glaucoma Medications Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 56. Taj Pharmaceuticals Major Business
Table 57. Taj Pharmaceuticals Glaucoma Medications Product and Services
Table 58. Taj Pharmaceuticals Glaucoma Medications Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Actavis Basic Information, Manufacturing Base and Competitors
Table 60. Actavis Major Business
Table 61. Actavis Glaucoma Medications Product and Services
Table 62. Actavis Glaucoma Medications Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. APOTEX Basic Information, Manufacturing Base and Competitors
Table 64. APOTEX Major Business
Table 65. APOTEX Glaucoma Medications Product and Services
Table 66. APOTEX Glaucoma Medications Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 68. Sun Pharma Major Business
Table 69. Sun Pharma Glaucoma Medications Product and Services
Table 70. Sun Pharma Glaucoma Medications Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Global Glaucoma Medications Sales by Manufacturer (2019-2021e) & (MT)
Table 72. Global Glaucoma Medications Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 73. Market Position of Manufacturers in Glaucoma Medications, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 74. Global Glaucoma Medications Production Capacity by Company, (MT): 2020 VS 2021
Table 75. Head Office and Glaucoma Medications Production Site of Key Manufacturer
Table 76. Global Glaucoma Medications Sales by Region (2016-2021e) & (MT)
Table 77. Global Glaucoma Medications Sales by Region (2021-2026) & (MT)
Table 78. Global Glaucoma Medications Revenue by Region (2016-2021e) & (USD Million)
Table 79. Global Glaucoma Medications Revenue by Region (2021-2026) & (USD Million)
Table 80. Global Glaucoma Medications Sales by Type (2016-2021e) & (MT)
Table 81. Global Glaucoma Medications Sales by Type (2021-2026) & (MT)
Table 82. Global Glaucoma Medications Revenue by Type (2016-2021e) & (USD Million)
Table 83. Global Glaucoma Medications Revenue by Type (2021-2026) & (USD Million)
Table 84. Global Glaucoma Medications Price by Type (2016-2021e) & (USD/Kg)
Table 85. Global Glaucoma Medications Price by Type (2021-2026) & (USD/Kg)
Table 86. Global Glaucoma Medications Sales by Application (2016-2021e) & (MT)
Table 87. Global Glaucoma Medications Sales by Application (2021-2026) & (MT)
Table 88. Global Glaucoma Medications Revenue by Application (2016-2021e) & (USD Million)
Table 89. Global Glaucoma Medications Revenue by Application (2021-2026) & (USD Million)
Table 90. Global Glaucoma Medications Price by Application (2016-2021e) & (USD/Kg)
Table 91. Global Glaucoma Medications Price by Application (2021-2026) & (USD/Kg)
Table 92. North America Glaucoma Medications Sales by Country (2016-2021e) & (MT)
Table 93. North America Glaucoma Medications Sales by Country (2021-2026) & (MT)
Table 94. North America Glaucoma Medications Revenue by Country (2016-2021e) & (USD Million)
Table 95. North America Glaucoma Medications Revenue by Country (2021-2026) & (USD Million)
Table 96. North America Glaucoma Medications Sales by Type (2016-2021e) & (MT)
Table 97. North America Glaucoma Medications Sales by Type (2021-2026) & (MT)
Table 98. North America Glaucoma Medications Sales by Application (2016-2021e) & (MT)
Table 99. North America Glaucoma Medications Sales by Application (2021-2026) & (MT)
Table 100. Europe Glaucoma Medications Sales by Country (2016-2021e) & (MT)
Table 101. Europe Glaucoma Medications Sales by Country (2021-2026) & (MT)
Table 102. Europe Glaucoma Medications Revenue by Country (2016-2021e) & (USD Million)
Table 103. Europe Glaucoma Medications Revenue by Country (2021-2026) & (USD Million)
Table 104. Europe Glaucoma Medications Sales by Type (2016-2021e) & (MT)
Table 105. Europe Glaucoma Medications Sales by Type (2021-2026) & (MT)
Table 106. Europe Glaucoma Medications Sales by Application (2016-2021e) & (MT)
Table 107. Europe Glaucoma Medications Sales by Application (2021-2026) & (MT)
Table 108. Asia-Pacific Glaucoma Medications Sales by Region (2016-2021e) & (MT)
Table 109. Asia-Pacific Glaucoma Medications Sales by Region (2021-2026) & (MT)
Table 110. Asia-Pacific Glaucoma Medications Revenue by Region (2016-2021e) & (USD Million)
Table 111. Asia-Pacific Glaucoma Medications Revenue by Region (2021-2026) & (USD Million)
Table 112. Asia-Pacific Glaucoma Medications Sales by Type (2016-2021e) & (MT)
Table 113. Asia-Pacific Glaucoma Medications Sales by Type (2021-2026) & (MT)
Table 114. Asia-Pacific Glaucoma Medications Sales by Application (2016-2021e) & (MT)
Table 115. Asia-Pacific Glaucoma Medications Sales by Application (2021-2026) & (MT)
Table 116. South America Glaucoma Medications Sales by Country (2016-2021e) & (MT)
Table 117. South America Glaucoma Medications Sales by Country (2021-2026) & (MT)
Table 118. South America Glaucoma Medications Revenue by Country (2016-2021e) & (USD Million)
Table 119. South America Glaucoma Medications Revenue by Country (2021-2026) & (USD Million)
Table 120. South America Glaucoma Medications Sales by Type (2016-2021e) & (MT)
Table 121. South America Glaucoma Medications Sales by Type (2021-2026) & (MT)
Table 122. South America Glaucoma Medications Sales by Application (2016-2021e) & (MT)
Table 123. South America Glaucoma Medications Sales by Application (2021-2026) & (MT)
Table 124. Middle East & Africa Glaucoma Medications Sales by Country (2016-2021e) & (MT)
Table 125. Middle East & Africa Glaucoma Medications Sales by Country (2021-2026) & (MT)
Table 126. Middle East & Africa Glaucoma Medications Revenue by Country (2016-2021e) & (USD Million)
Table 127. Middle East & Africa Glaucoma Medications Revenue by Country (2021-2026) & (USD Million)
Table 128. Middle East & Africa Glaucoma Medications Sales by Type (2016-2021e) & (MT)
Table 129. Middle East & Africa Glaucoma Medications Sales by Type (2021-2026) & (MT)
Table 130. Middle East & Africa Glaucoma Medications Sales by Application (2016-2021e) & (MT)
Table 131. Middle East & Africa Glaucoma Medications Sales by Application (2021-2026) & (MT)
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Glaucoma Medications Typical Distributors
Table 135. Glaucoma Medications Typical Customers
List of Figures
Figure 1. Glaucoma Medications Picture
Figure 2. Global Glaucoma Medications Sales Market Share by Type in 2020
Figure 3. Prostaglandin Analogs
Figure 4. Beta Blockers
Figure 5. Alpha Agonists
Figure 6. Carbonic Anhydrase Inhibitors
Figure 7. Combined Medications
Figure 8. Global Glaucoma Medications Sales Market Share by Application in 2020
Figure 9. Open-angle Glaucoma
Figure 10. Closed-angle Glaucoma
Figure 11. Global Glaucoma Medications Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 12. Global Glaucoma Medications Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Glaucoma Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Glaucoma Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Glaucoma Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Glaucoma Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Glaucoma Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Glaucoma Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Glaucoma Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Glaucoma Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Glaucoma Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Glaucoma Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Glaucoma Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Glaucoma Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Glaucoma Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Glaucoma Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Glaucoma Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Glaucoma Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Glaucoma Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Glaucoma Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Glaucoma Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Glaucoma Medications Sales (2016-2026) & (MT)
Figure 33. Global Glaucoma Medications Production Capacity (2016-2026) & (MT)
Figure 34. Global Glaucoma Medications Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Glaucoma Medications Market Drivers
Figure 36. Glaucoma Medications Market Restraints
Figure 37. Glaucoma Medications Market Trends
Figure 38. Global Glaucoma Medications Sales Market Share by Manufacturer in 2020
Figure 39. Global Glaucoma Medications Revenue Market Share by Manufacturer in 2020
Figure 40. Glaucoma Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Glaucoma Medications Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Glaucoma Medications Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Glaucoma Medications Sales Market Share by Region (2016-2026)
Figure 44. Global Glaucoma Medications Revenue Market Share by Region (2016-2026)
Figure 45. North America Glaucoma Medications Revenue (2016-2026) & (USD Million)
Figure 46. Europe Glaucoma Medications Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Glaucoma Medications Revenue (2016-2026) & (USD Million)
Figure 48. South America Glaucoma Medications Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Glaucoma Medications Revenue (2016-2026) & (USD Million)
Figure 50. Global Glaucoma Medications Sales Market Share by Type (2016-2026)
Figure 51. Global Glaucoma Medications Revenue Market Share by Type (2016-2026)
Figure 52. Global Glaucoma Medications Price by Type (2016-2026) & (USD/Kg)
Figure 53. Global Glaucoma Medications Sales Market Share by Application (2016-2026)
Figure 54. Global Glaucoma Medications Revenue Market Share by Application (2016-2026)
Figure 55. Global Glaucoma Medications Price by Application (2016-2026) & (USD/Kg)
Figure 56. North America Glaucoma Medications Sales Market Share by Country (2016-2026)
Figure 57. North America Glaucoma Medications Revenue Market Share by Country (2016-2026)
Figure 58. North America Glaucoma Medications Sales Market Share by Type (2016-2026)
Figure 59. North America Glaucoma Medications Sales Market Share by Application (2016-2026)
Figure 60. Europe Glaucoma Medications Sales Market Share by Country (2016-2026)
Figure 61. Europe Glaucoma Medications Revenue Market Share by Country (2016-2026)
Figure 62. Europe Glaucoma Medications Sales Market Share by Type (2016-2026)
Figure 63. Europe Glaucoma Medications Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Glaucoma Medications Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Glaucoma Medications Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Glaucoma Medications Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Glaucoma Medications Sales Market Share by Application (2016-2026)
Figure 68. South America Glaucoma Medications Sales Market Share by Country (2016-2026)
Figure 69. South America Glaucoma Medications Revenue Market Share by Country (2016-2026)
Figure 70. South America Glaucoma Medications Sales Market Share by Type (2016-2026)
Figure 71. South America Glaucoma Medications Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Glaucoma Medications Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Glaucoma Medications Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Glaucoma Medications Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Glaucoma Medications Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界の緑内障治療市場規模・現状・予測（2021年-2027年） Glaucoma is chronic, degenerative disorder that damages the eye's optic nerve, may result in vision loss and blindness. Factors such, high prevalence of glaucoma, technological advancement in diagnostic technique, rising treatment awareness are driving the market growth of glaucoma therapeutics glob…- 世界の抗緑内障薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-glaucoma Drug Market The global Anti-glaucoma Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes…
- 世界の抗緑内障薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-glaucoma Drug Market The global Anti-glaucoma Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes…
- 世界の緑内障治療薬市場 2021：企業別、地域別、種類・用途別 The Glaucoma Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界の緑内障市場規模・現状・予測（2021年-2027年） Glaucoma is an asymptomatic eye-related disorder that occurs due to the buildup of fluid pressure inside the eye. This leads to damage of the optic nerve in the eye, and is a hereditary disorder. Immediate treatment of people suffering from glaucoma is essential as glaucoma in severe cases may resul…